Lilly scientist pressured study to downplay Oraflex harms
AP reports sworn deposition reveals senior Eli Lilly researcher urged writer Charles B Vaughan to soften side effects of arthritis drug Oraflex. The drug, approved in 1982 and withdrawn in 1982 after deaths linked in Britain and the U.S., faces lawsuits by patients alleging severe reactions.
MENTIONED IN THIS ARTICLE
Indianapolis
Eli Lilly and Co
Lilly
U.S
Britain
United States
Charles B. Vaughan
W. Ian Shedden
Food and Drug Administration
Vaughan
Also Mentioned on This Page
Oraflex
William Lister
Lilly Marketing
Ron Culp
Culp
European Journal of Rheumatology and
A.M. Kligman
K.H. Kaidbey
The
University of Pennsylvania
Discount Center
API
Isk
He Reedi
Evetubte Tor Od Han Eherteed Bern Tr
Bounty
Coca Cola
Sprite
Main Street
N. Grandview
W. County RD
W. University
E. 8Th ST